Dr. Andrew Pountain is an Assistant Professor in the Department of Microbiology and Molecular Genetics in UTHealth Houston’s McGovern Medical School. Andrew attained his Ph.D. in 2018 from the University of Glasgow for his thesis work in molecular parasitology in the laboratory of Prof. Michael Barrett. He did his postdoctoral training first within MMG itself from 2018-2020, studying fungal pathogenesis within the laboratory of Dr. Michael Lorenz, then at the New York University School of Medicine where he investigated bacterial transcriptional dynamics with Dr. Itai Yanai. He joined the faculty of the Department in 2024.
My research program aims to identify principles underlying microbial transcriptional biology. Gene expression is shaped by multiple interconnecting factors from the transcriptional regulatory network, to the physiological state of a cell in its environment, to stochastic events at the molecular level. My goal is to develop frameworks that enable understanding of these complex factors at a systems level and their relationship to cellular physiology and decision making. Building on my background in microbial pathogens, transcriptional technologies, and systems biology, my research interests lie in two main areas:
Quorum-sensing agr system of Staphylococcus aureus primes gene expression for protection from lethal oxidative stress. bioRxiv. 2024 Feb 28;. doi: 10.1101/2023.06.08.544038. PubMed PMID: 37333372; PubMed Central PMCID: PMC10274873.
Transcription-replication interactions reveal bacterial genome regulation. Nature. 2024 Feb;626(7999):661-669. doi: 10.1038/s41586-023-06974-w. Epub 2024 Jan 24. PubMed PMID: 38267581; PubMed Central PMCID: PMC10923101.
Candida auris-macrophage cellular interactions and transcriptional response. Infect Immun. 2023 Nov 16;91(11):e0027423. doi: 10.1128/iai.00274-23. Epub 2023 Oct 10. PubMed PMID: 37815367; PubMed Central PMCID: PMC10652981.
The tempo and mode of gene regulatory programs during bacterial infection. Cell Rep. 2022 Oct 11;41(2):111477. doi: 10.1016/j.celrep.2022.111477. PubMed PMID: 36223751; PubMed Central PMCID: PMC9741813.
Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response. PLoS Negl Trop Dis. 2022 Sep;16(9):e0010779. doi: 10.1371/journal.pntd.0010779. eCollection 2022 Sep. PubMed PMID: 36170238; PubMed Central PMCID: PMC9581426.
Interactions of Both Pathogenic and Nonpathogenic CUG Clade Candida Species with Macrophages Share a Conserved Transcriptional Landscape. mBio. 2021 Dec 21;12(6):e0331721. doi: 10.1128/mbio.03317-21. Epub 2021 Dec 14. PubMed PMID: 34903044; PubMed Central PMCID: PMC8669484.
Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs. PLoS Pathog. 2020 Nov;16(11):e1008932. doi: 10.1371/journal.ppat.1008932. eCollection 2020 Nov. PubMed PMID: 33141865; PubMed Central PMCID: PMC7710103.
The Paralogous Transcription Factors Stp1 and Stp2 of Candida albicans Have Distinct Functions in Nutrient Acquisition and Host Interaction. Infect Immun. 2020 Apr 20;88(5). doi: 10.1128/IAI.00763-19. Print 2020 Apr 20. PubMed PMID: 32094252; PubMed Central PMCID: PMC7171245.
Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites. Wellcome Open Res. 2019;4:176. doi: 10.12688/wellcomeopenres.15452.1. eCollection 2019. PubMed PMID: 32133420; PubMed Central PMCID: PMC7041363.
Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus. Antiviral Res. 2019 Oct;170:104551. doi: 10.1016/j.antiviral.2019.104551. Epub 2019 Jul 12. PubMed PMID: 31306674; PubMed Central PMCID: PMC6891261.